Novo Nordisk Frontier 4

News

Novo Nordisk ousts CEO

Talks to replace Novo Nordisk CEO lasted several weeks, board chair says

Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company's board Chair Helge Lund told Reuters on Friday.

Fox Business on MSN · 3h

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.

NBC4 Washington · 8h

Novo Nordisk CEO to step down as Wegovy maker faces growing competition

The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post “for a period to support a smooth transition to new leadership.”

1hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

2don MSN

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

Zacks Investment Research on MSN1d

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market. Following the ...

3hon MSN

Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results